YOUR LOGO HERE BANDAGE SPRAY

Manufacturer
Dixon Investments, Inc.
Effective date
2026-10-01
Label type
HUMAN OTC DRUG LABEL
Version
6
Source
daily-update
Hydrated at
2026-10-06 02:02:54

Label at a glance#

ProductYour Logo Here Bandage Aid
Active ingredientBENZOCAINE, BENZETHONIUM CHLORIDE
Label structure11 sections

Indications and uses

First Aid to help protect against infection in minor cuts scrapes burns 

Dosage and administration

clean the affected area shake can well before using hold can 4 to 6 inches away from injury and spray area until wet for adult institutional use only not intended for use on children 

Label contents#

Full prescribing information#

Active Ingredients

OTC - ACTIVE INGREDIENT SECTION

Benzethonium Chloride 0.2% w/w
Benzocaine 3.2% w/w 

Purpose

OTC - PURPOSE SECTION

Topical Antiseptic
Topical Anesthetic 

Uses

INDICATIONS & USAGE SECTION

First Aid to help protect against infection in
minor cuts
scrapes
burns 

Warnings

WARNINGS SECTION

For external use only

Flammable
keep away from fire or flame
contents under pressure
do not puncture or incinerate container
do not expose to temperatures above 120°(F) 

Do not use

OTC - DO NOT USE SECTION

in or near the eyes or other mucous membranes
in case of serious burn
in deep puncture wounds
for prolonged period of time
on large portions of the body 

Stop use and ask a doctor

OTC - STOP USE SECTION

if redness, swelling, or irritation occurs
infection occurs
condition persists or worsens
symptoms persist for more than 7 days 

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

clean the affected area
shake can well before using
hold can 4 to 6 inches away from injury and spray area until wet
for adult institutional use only
not intended for use on children 

Other information

OTHER SAFETY INFORMATION

avoid inhaling
use only as directed
intentional misuse by deliberately concentrating and inhaling the contents may be harmful or fatal 

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Ethyl Alcohol, PVP-VA Copolymer, N-Butane, Propane, Isobutane

Principal Display

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

image descriptionimage description

FDA-Initiated Inactive NDC Indexing#

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
BENZETHONIUM CHLORIDEACTIVE INGREDIENTPH41D057441
BENZOCAINEACTIVE INGREDIENTU3RSY48JW51
BENZETHONIUMACTIVE MOIETY1VU15B70BP1
BENZOCAINEACTIVE MOIETYU3RSY48JW51
ALCOHOLINACTIVE INGREDIENT3K9958V90M1
BUTANEINACTIVE INGREDIENT6LV4FOR43R1
COPOVIDONE K25-31INACTIVE INGREDIENTD9C330MD8B1
ISOBUTANEINACTIVE INGREDIENTBXR49TP6111
PROPANEINACTIVE INGREDIENTT75W9911L61

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 10 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
52982-10552982-105-03

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 7 matching rows.

Source Document#

Source XML

Older Hydrated Versions#

Version, Effective date, Source table
VersionEffective dateSourceHydrated
52025-01-28full-release2026-06-01 00:53:58

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 42 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
COPOVIDONE K25-31COPOVIDONE K25-31D9C330MD8BSUSPENSION / ORAL172 mgExact identifier — unii candidate
32 equally ranked IID candidates
COPOVIDONE K25-31COPOVIDONE K25-31D9C330MD8BCAPSULE / ORAL1346 mgExact identifier — unii candidate
32 equally ranked IID candidates
COPOVIDONE K25-31COPOVIDONE K25-31D9C330MD8BTABLET, DELAYED RELEASE / ORAL168 mgExact identifier — unii candidate
32 equally ranked IID candidates
COPOVIDONE K25-31COPOVIDONE K25-31D9C330MD8BCAPSULE / ORAL1346 mgExact identifier — unii candidate
32 equally ranked IID candidates
PROPANEPROPANET75W9911L6AEROSOL, FOAM / TOPICAL55 %w/wExact identifier — unii+route
2 equally ranked IID candidates
BUTANEBUTANE6LV4FOR43RAEROSOL / TOPICALNAExact identifier — unii+route
4 equally ranked IID candidates
ISOBUTANEISOBUTANEBXR49TP611AEROSOL, SPRAY / TOPICAL4484 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
COPOVIDONE K25-31COPOVIDONE K25-31D9C330MD8BSUSPENSION / ORAL172 mgExact identifier — unii candidate
32 equally ranked IID candidates
COPOVIDONE K25-31COPOVIDONE K25-31D9C330MD8BTABLET, FILM COATED, EXTENDED RELEASE / ORAL53 mgExact identifier — unii candidate
32 equally ranked IID candidates
COPOVIDONE K25-31COPOVIDONE K25-31D9C330MD8BPOWDER, FOR SUSPENSION / ORAL5917 mgExact identifier — unii candidate
32 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MAEROSOL, SPRAY / TOPICAL561 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
COPOVIDONE K25-31COPOVIDONE K25-31D9C330MD8BTABLET, FILM COATED / ORAL5917 mgExact identifier — unii candidate
32 equally ranked IID candidates
COPOVIDONE K25-31COPOVIDONE K25-31D9C330MD8BCAPSULE, COATED PELLETS / ORAL88 mgExact identifier — unii candidate
32 equally ranked IID candidates
COPOVIDONE K25-31COPOVIDONE K25-31D9C330MD8BTABLET, EXTENDED RELEASE / ORAL300 mgExact identifier — unii candidate
32 equally ranked IID candidates
COPOVIDONE K25-31COPOVIDONE K25-31D9C330MD8BFILM, EXTENDED RELEASE / TRANSDERMALNAExact identifier — unii candidate
32 equally ranked IID candidates
COPOVIDONE K25-31COPOVIDONE K25-31D9C330MD8BCAPSULE, EXTENDED RELEASE / ORAL200 mgExact identifier — unii candidate
32 equally ranked IID candidates
BUTANEBUTANE6LV4FOR43RAEROSOL, FOAM / TOPICAL27 %w/wExact identifier — unii+route
4 equally ranked IID candidates
COPOVIDONE K25-31COPOVIDONE K25-31D9C330MD8BTABLET, CHEWABLE / ORAL5 mgExact identifier — unii candidate
32 equally ranked IID candidates
COPOVIDONE K25-31COPOVIDONE K25-31D9C330MD8BTABLET / SUBLINGUAL54 mgExact identifier — unii candidate
32 equally ranked IID candidates
COPOVIDONE K25-31COPOVIDONE K25-31D9C330MD8BTABLET, ORALLY DISINTEGRATING / ORAL35 mgExact identifier — unii candidate
32 equally ranked IID candidates
COPOVIDONE K25-31COPOVIDONE K25-31D9C330MD8BCAPSULE, DELAYED RELEASE / ORAL199 mgExact identifier — unii candidate
32 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MAEROSOL, SPRAY / TOPICAL561 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
PROPANEPROPANET75W9911L6AEROSOL, FOAM / TOPICAL55 %w/wExact identifier — unii+route
2 equally ranked IID candidates
COPOVIDONE K25-31COPOVIDONE K25-31D9C330MD8BTABLET, FILM COATED, EXTENDED RELEASE / ORAL53 mgExact identifier — unii candidate
32 equally ranked IID candidates
COPOVIDONE K25-31COPOVIDONE K25-31D9C330MD8BPELLET / ORAL1653 mgExact identifier — unii candidate
32 equally ranked IID candidates
COPOVIDONE K25-31COPOVIDONE K25-31D9C330MD8BFILM, EXTENDED RELEASE / TRANSDERMALNAExact identifier — unii candidate
32 equally ranked IID candidates
COPOVIDONE K25-31COPOVIDONE K25-31D9C330MD8BCAPSULE, DELAYED RELEASE / ORAL199 mgExact identifier — unii candidate
32 equally ranked IID candidates
COPOVIDONE K25-31COPOVIDONE K25-31D9C330MD8BCAPSULE, EXTENDED RELEASE / ORAL200 mgExact identifier — unii candidate
32 equally ranked IID candidates
COPOVIDONE K25-31COPOVIDONE K25-31D9C330MD8BTABLET, ORALLY DISINTEGRATING / ORAL35 mgExact identifier — unii candidate
32 equally ranked IID candidates
BUTANEBUTANE6LV4FOR43RAEROSOL, FOAM / TOPICAL27 %w/wExact identifier — unii+route
4 equally ranked IID candidates
COPOVIDONE K25-31COPOVIDONE K25-31D9C330MD8BTABLET / ORAL6374 mgExact identifier — unii candidate
32 equally ranked IID candidates
COPOVIDONE K25-31COPOVIDONE K25-31D9C330MD8BPELLET / ORAL1653 mgExact identifier — unii candidate
32 equally ranked IID candidates
COPOVIDONE K25-31COPOVIDONE K25-31D9C330MD8BTABLET / SUBLINGUAL54 mgExact identifier — unii candidate
32 equally ranked IID candidates
COPOVIDONE K25-31COPOVIDONE K25-31D9C330MD8BTABLET, EXTENDED RELEASE / ORAL300 mgExact identifier — unii candidate
32 equally ranked IID candidates
COPOVIDONE K25-31COPOVIDONE K25-31D9C330MD8BTABLET / ORAL6374 mgExact identifier — unii candidate
32 equally ranked IID candidates
ISOBUTANEISOBUTANEBXR49TP611AEROSOL, SPRAY / TOPICAL4484 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
COPOVIDONE K25-31COPOVIDONE K25-31D9C330MD8BTABLET, FILM COATED / ORAL5917 mgExact identifier — unii candidate
32 equally ranked IID candidates
COPOVIDONE K25-31COPOVIDONE K25-31D9C330MD8BTABLET, DELAYED RELEASE / ORAL168 mgExact identifier — unii candidate
32 equally ranked IID candidates
COPOVIDONE K25-31COPOVIDONE K25-31D9C330MD8BPOWDER, FOR SUSPENSION / ORAL5917 mgExact identifier — unii candidate
32 equally ranked IID candidates
COPOVIDONE K25-31COPOVIDONE K25-31D9C330MD8BCAPSULE, COATED PELLETS / ORAL88 mgExact identifier — unii candidate
32 equally ranked IID candidates
BUTANEBUTANE6LV4FOR43RAEROSOL / TOPICALNAExact identifier — unii+route
4 equally ranked IID candidates
COPOVIDONE K25-31COPOVIDONE K25-31D9C330MD8BTABLET, CHEWABLE / ORAL5 mgExact identifier — unii candidate
32 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Your Logo Here Bandage AidBENZETHONIUM CHLORIDE AND BENZOCAINEDixon Investments, Inc.b2fdd15e-8305-4c0d-9475-c3a1b49a79a12025-01-28WarningsExact identifier
ndc (package): 52982-105-03
ndc (product): 52982-105
ndc11 (package): 52982010503
spl set id: b2fdd15e-8305-4c0d-9475-c3a1b49a79a1

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.